MHRA approves prostate cancer imaging agent trofolastat
Approximately 55,100 new cases of prostate cancer are diagnosed every year in the UK
Read More
Tag: MHRA
Anthony Harnden
The MHRA has appointed Anthony Harnden as Chair
Read More
MHRA approves Astellas’ Vyloy combination for gastric cancer
Most cases go undetected until an advanced stage, as the disease rarely causes early symptoms
Read More
eXmoor pharma’s manufacturing facility receives licence from MHRA
The company’s Cell & Gene Therapy Centre can now offer a full range of GMP services
Read More
Research shows new technique could cut time to detect polio in half
This is the first time that this type of scientific method has been used to detect polio
Read More
Elfabrio receives vital MHRA authorisation
The therapy involves long-term enzyme replacement therapy for aduls with Fabry disease
Read More
Invizius gets MHRA Approval for H-Guard research
First-in-human study to be undertaken at the Manchester University Hospitals NHS Foundation Trust
Read More
GSK’s Arexvy authorised by MHRA
Therapy is the first respiratory syncytial virus vaccine specifically developed for older adults
Read More
Incyte’s Opzelura gets MHRA authorisation
Therapy involves the treatment of non-segmental vitiligo among adults and adolescents
Read More
CSL’s Hemgenix receives MHRA authorisation
Treatment is the only single infusion gene therapy for the treatment of severe haemophilia B
Read More
ABPI responds to rebooted MHRA clinical trials framework
Measures include a requirement to publicly register studies and share results among research participants
Read More
Celadon receives good manufacturing practice approval
MHRA approval relates to the company’s midlands-based drug development facilities
Read More
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
